to evaluate postgrafting prophylaxis for graft versus host disease , we studied these patients in a sequential , prospective , randomized trial that compared the effect of a combination of methotrexate and cyclosporine ( n = 43 ) with that of cyclosporine alone ( n = 50 ) .
C0018133
graft versus host disease
C0010592
cyclosporine